Is Tarsus Pharmaceuticals TARS stock failing to hold levels Tarsus Pharmaceuticals posts wider than expected EPS loss Exponent EXPO Stock Is It Testing Key Levels Steady Decline 20260427 What drives future growth of BioAffinity BIAF stock Q3 2025 Earnings Fall Short BOTJ James Bank dips 082 in todays session following Q1 2025 earnings release with no publicly shared revenue or EPS figures Duke Energy Corporation DUK Robinson Nuclear Plant License Renewal Bolsters LongTerm Cash Flow and Decarbonization Trajectory IBRX ImmunityBio reports narrower than projected Q4 2025 per share loss while its stock holds steady for the trading session SP Software Services Select Industry ETF XSW Divergent Tech SubSector Performance Flashes Broad Market Risk Warning Signal KraneShares CSI China Internet ETF KWEB Assessing Its Role As A Contrarian Play For Chinese Equity Recovery Salesforce Inc CRM Poised for Upside From Early Anthropic Stake Ahead of Expected 2026 1T AI IPO Black Titan BTTC Stock Outlook Growth Potential and Key Risks